Genetic characterization and susceptibility for sarcoidosis in Japanese patients: Risk factors of BTNL2 gene polymorphisms and HLA class II alleles

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 11, 2012, Pages 7109-7115

  Suzuki, Hitomi ^a,b   Ota, Masao ^c   Meguro, Akira ^a   Katsuyama, Yoshihiko ^c   Kawagoe, Tatukata ^a   Ishihara, Mami ^a,d   Asukata, Yuri ^a   Takeuchi, Masaki ^a   Ito, Norihiko ^a   Shibuya, Etsuko ^a   Nomura, Eiichi ^a   Uemoto, Riyo ^a   Nishide, Tadayuki ^a   Namba, Kenichi ^e   Kitaichi, Nobuyoshi ^f   Morimoto, Shin Ichiro ^g   Kaburaki, Toshikatsu ^h   Ando, Yasutaka ⁱ   Takenaka, Shinobu ^j   Nakamura, Jutaro ^a   Saeki, Kozou ^b   Ohno, Shigeaki ^e   Inoko, Hidetoshi ^k   Mizuki, Nobuhisa ^a   more..

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Saeki Eye Clinic   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Hiyoshi Ophthalmic Clinic   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^g FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ KITASATO INSTITUTE HOSPITAL   (Japan)

^j KUMAMOTO CITY HOSPITAL   (Japan)

^k TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BTNL2 GENE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN; CASE CONTROL STUDY; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; JAPAN; PHENOTYPE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS;

BTNL2 PROTEIN, HUMAN; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA-DQB1 ANTIGEN; MEMBRANE PROTEIN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84871900961     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10491     Document Type: Article

References (45)

1. Iannuzzi MC,Rybicki BA,Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–2165.
2. Ohguro N,Sonoda K,Takeuchi M,Matsumara M,Mochizuki M. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophtalmol. 2012;56:432–435.
3. Ishihara M,Ishida T,Inoko H,et al. HLA serological and class II genotyping in sarcoidosis patients in Japan. Jpn J Ophthalmol. 1996;40:86–94.
4. Foley PJ,McGrath DS,Puscinska E,et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol. 2001;25: 272–277.
5. Rossman MD,Thompson B,Frederick M,et al. HLADRB1* 1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73:720–735.
6. Rybicki BA,Maliarik MJ,Poisson LM,et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med. 2003;167:444–449.
7. Sato H,Woodhead FA,Ahmad T,et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet. 2010;19:4100–4111.
8. Valentonyte R,Hampe J,Huse K,et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet. 2005;37:357–364.
9. Rhodes DA,Stammers M,Malcherek G,Beck S,Trowsdale J. The cluster of BTN genes in the extended major histocompatibility complex. Genomics. 2001;71:351–362.
10. Nguyen T,Liu XK,Zhang Y,Dong C. BTNL2,a butyrophilinlike molecule that functions to inhibit T cell activation. J Immunol. 2006;176:7354–7360.
11. Rybicki BA,Walewski JL,Maliarik MJ,Kian H,Iannuzzi MC,Access Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet. 2005;77:491–499.
12. Spagnolo P,Sato H,Grutters JC,et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens. 2007;70:219–227.
13. Wijnen PA,Voorter CE,Nelemans PJ,Verschakelen JA,Bekers O,Drent M. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? Hum Immunol. 2011;72:342–347.
14. Orozoco G,Eerligh P,Sanchez E,et al. Analysis of a functional BTNL2 polymorphism in type I diabetes,rheumatoid arthritis,and systemic lupus erythematosus. Hum Immunol. 2005;66: 1235–1241.
15. Traherne JA,Barcellos LF,Sawcer SJ,et al. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15. Hum Mol Genet. 2006;15:155–161.
16. Simmonds MJ,Heward JM,Barrett JC,Franklyn JA,Gough SC. Association of the BTNL2 rs2076530 single nucleotide polymorphisms with Graves’ disease appears to be secondary to DRB1 exon 2 position b74. Clin Endocrinol. 2006;65:429–432.
17. Sato H,Spagnolo P,Silveria L,et al. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Tissue Antigens. 2007;70:480–486.
18. Mochida A,Kinouchi Y,Negoro K,et al. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502. Tissue Antigens. 2007;70:128–135.
19. The Japanese Society of Sarcoidosis and Other Granulomatous Disorders (JSSOG). Diagnostic criteria and guidelines for sarcoidosis-2006. Jpn J Sarcoidosis and Granulomatous Disorders. 2007;22:89–101.
20. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS),the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee,February 1999. Am J Respir Crit Care Med. 1999;160:736–755.
21. Barrett JC,Fry B,Maller J,Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21:263–265.
22. Gabriel SB,Schaffner SF,Nguyen H,et al. The structure of haplotype blocks in the human genome. Science. 2002;296: 2225–2229.
23. Qin ZS,Niu T,Liu J. Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet. 2002;71:1242–1247.
24. Svejgaard A,Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens. 1994;43:18–27.
25. Li Y,Wollnik B,Pabst S,et al. BTNL2 gene variant and sarcoidosis. Thorax. 2006;61:273–274.
26. Hedfors E,Lindstrom F. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens. 1983;22:200–203.
27. Ishihara M,Ohno S,Ishida T,et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens. 1994;43: 238–241.
28. Rutherford RM,Brutsche MH,Kearns M,Bourke M,Stevens F,Gilmartin JJ. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:191–198.
29. Grunewald J,Brynedal B,Darlington P,et al. Different HLADRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res. 2010;11:25.
30. Zhou Y,Shen Li,Zhang Y,Jiang D,Li H. Human leukocyte antigen-A,-B,and –DRB1 alleles and sarcoidosis in Chinese Han subjects. Human Immunol. 2011;72:571–575.
31. Ina Y,Takada K,Yamamoto M,Morishita M,Senda Y,Torii Y. HLA and sarcoidosis in the Japanese. Chest. 1989;95:1257–1261.
32. Todd JA,Acha-Orbea H,Bell JI,et al. A molecular basis for MHC class II-associated autoimmunity. Science. 1988;240: 1003–1009.
33. Stern LJ,Brown JH,Jardetzky TS,et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994;368:215–221.
34. Zhang L,Chen Y,Wong HS,Zhou S,Mamitsuka H,Zhu S. TEPITOPEpan: extending TEPITOPE for peptide binding prediction covering over 700 HLA-DR molecules. PLoS One. 2012;7:e30483.
35. Voorter CE,Drent M,van der Berg-Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101. Human Immunol. 2005;66:826–835.
36. Bogunia-Kubik K,Tomeczko J,Suchnicki K,Lange A. HLADRB1* 03,DRB1*11 or DRB1*12 and their respective DR3 specificities in clinical variants of sarcoidosis. Tissue Antigens. 2001;57:87–90.
37. Mrazek F,Holla LI,Hutyrova B,et al. Association of tumor necrosis factor-alpha,lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with L¨ofgre’s syndrome in Czech patients with sarcoidosis. Tissue Antigens. 2005;65:163–171.
38. Amicosante M,Puxeddu E,Salitini C. Reactivity to mycobacterial antigens by patients with Lofgren’s syndrome as a model of phenotypic susceptibility to disease and disease progression. Am J Respir Crit Care Med. 2009;180:685.
39. Berlin M,Fogdell-Hahn A,Olerup O,Eklund A,Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 1997;156: 1601–1605.
40. Grunewald J,Eklund A,Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med. 2004;169:696–702.
41. Sato H,Grutters JC,Pantelidis P,et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol. 2002;27:406–412.
42. Stammers M,Rowen L,Rhodes D,Trowsdale J,Beck S. BTL-II: a polymorphic locus with homology to the butyrophilin gene family,located at the border of the major histocompatibility complex class II and class III regions in human and mouse. Immunogenetics. 2000;51:373–382.
43. Johnson CM,Traherne JA,Jamieson SE,et al. Analysis of the BTNL2 truncating splice site mutation in tuberculosis,leprosy and Crohn’s disease. Tissue Antigens. 2007;69:236–241.
44. Tesmer LA,Lundy SK,Sarkar S,Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87–113.
45. Facco M,Cabrelle A,Teramo A,et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax. 2011;66:144–150.